A world of trouble - Which risks loom largest for businesses in 2013?

Jan 12th 2013 |From the print edition

IN THE MAGIC MOUNTAIN by Thomas Mann, a young businessman visits his ailing

cousin in a sanatorium in Davos, in the Swiss Alps. The businessman starts to

feel unwell himself. The sanatorium s chief doctor, who also owns the place,

advises him to rest. He ends up staying for seven interminable years.

Reading reports on risk can have much the same effect. The more you read, the

more risks you see; eventually, you succumb to nervous exhaustion. This week

saw the publication of two particularly angst-inducing accounts: Global Risks

2013 , by the World Economic Forum (which meets in Davos this month), and Top

Risks 2013 , by the Eurasia Group, a consultancy.

It is nevertheless worth pouring yourself a stiff whisky and ploughing through

all those pages about chronic labour-market imbalances and the unforeseen

consequences of climate-change mitigation . These reports not only provide

warnings about dangers that can be avoided by better planning or clearer

thinking. They also suggest opportunities for it is a basic law of business

that one man s cliff is another s ladder.

The WEF explores some familiar problems, such as rising inequality and the

fragility of the global economic system (which is being tested anew by the

unfamiliar combination of bold monetary policies and austere fiscal ones). But

it focuses on two more unfamiliar threats that lie just beneath the surface of

everyday life, in your inbox and your medicine cabinet.

The WEF speculates that digital wildfires could wreak global havoc. The

internet spreads disinformation in the blink of an eye. Traders, human and

robotic, act on it faster than you can say flash crash . In July 2012 oil

prices rose by more than $1 a barrel when a Twitter user, impersonating the

Russian interior minister, tweeted that Syria s president, Bashar Assad, had

been killed or injured . In October NASDAQ halted trading in Google shares

when a leaked earnings report led to a $22 billion plunge in the company s

market capitalisation. And in November the BBC was rocked when an irresponsible

news programme prompted Twitter users to accuse an innocent politician of

paedophilia.

Companies do need to take these risks seriously, but digital wildfires might

not be quite the infernos that the WEF fears. The internet often polices

itself. A Twitter rumour that the New York Stock Exchange had been flooded

during Hurricane Sandy was quickly corrected by other Twitter users. Companies

are developing programs, such as Truthy, TEASE and the wonderfully named

LazyTruth, that help people to assess the credibility of online information.

And businesspeople have always had to exercise judgment when confronted with

new information, whether it arrives via fibre-optic cable or carrier pigeon.

The report is more worrying on the subject of antibiotics. These wonder-pills

have saved more lives than almost any other invention. But there are signs that

they are losing some of their potency, thanks in part to rampant overuse. The

number of infections that are resistant to treatment by antibiotics is on the

rise, a problem that may cost America s health system between $21 billion and

$34 billion a year. And the pace of development of new antibiotics is slowing,

as drug firms shift their attention to chronic illnesses such as diabetes and

hypertension or to new technologies such as nanotechnology.

The report argues that it should be much harder to get hold of antibiotics.

Consider China, where many hospitals make much of their income from selling the

drugs they prescribe. One study found that 98% of children with the common cold

at a Beijing hospital were given antibiotics which are useless for treating

viral infections. In India strong antibiotics are sold without a prescription.

Almost everywhere antibiotics are overused in farming fish and livestock. The

WEF also argues that companies and non-profits need to collaborate more to

develop more drugs. GlaxoSmithKline and the Bill & Melinda Gates Foundation

have both acted as pioneers here through their open lab approach to research.

Glaxo has opened its Tres Cantos research facilities to academic and government

scientists in order to collaborate on discovering new antibiotics. The Gates

Foundation has organised an accelerator programme that brings together research

teams from academia and private companies such as Abbott Laboratories,

AstraZeneca, Bayer, Eli Lilly and Glaxo.

The world is fragile

The Eurasia Group s survey focuses exclusively on political risks. Eurasia s

big idea is that the worst risks now come from the emerging world. The rich

world has demonstrated that it is capable of managing risks fairly well indeed,

many rich countries are antifragile (a word that means adept at coping with

disruption and is the title of a book by Nassim Taleb, a scholar of risk).

America could be on the cusp of strong growth. But the emerging world has much

less experience of managing volatility or coping with crashes, says Eurasia.

This is too optimistic about the rich world. Spain and Italy are hardly

antifragile, and America is testing the markets patience. But it is true that

businessfolk pay too little attention to political risk in the emerging world

(which is likely to account for three-quarters of global economic growth in

2020). Investors often lump very different countries together into a single

asset class (eg, the BRICs). Yet as Eurasia makes clear, Russia is much riskier

than Brazil: its energy industry is stalling and its middle class is losing

patience with kleptocracy. Companies too often ignore the detailed knowledge of

old-fashioned country managers, opting instead for a more regional approach.

They should not. The more the centre of economic gravity shifts towards

emerging markets, the more businesspeople need to recognise that the emerging

world is a horribly complicated place.

http://www.Economist.com/blogs/schumpeter

From the print edition: Business